Cita APA

Verheijen, R. B., Swart, L. E., Beijnen, J. H., Schellens, J. H. M., Huitema, A. D. R., & Steeghs, N. (2017). Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: Opportunities for dose optimization. Cancer Chemother Pharmacol.

Chicago Style Citation

Verheijen, R. B., L. E. Swart, J. H. Beijnen, J. H. M. Schellens, A. D. R. Huitema, i N. Steeghs. "Exposure-survival Analyses of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients: Opportunities for Dose Optimization." Cancer Chemother Pharmacol 2017.

Cita MLA

Verheijen, R. B., et al. "Exposure-survival Analyses of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients: Opportunities for Dose Optimization." Cancer Chemother Pharmacol 2017.